In a recent study, we showed that the expression of wild-type p53 protein is required for the growth-inhibitory effects of IL-8-CXCR2 signaling on two different prostate cancer cell lines [62], which provides experimental evidence to support our hypothesis. This evidence concerns the gene CXCL8 and prostate cancer.